Home › Attention Deficit Hyperactivity Disorder › California › Los Angeles
Attention Deficit Hyperactivity Disorder clinical trials in Los Angeles, CA
4 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
RecruitingPhase 3
- Clinical Research Site, Los Angeles
Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
Recruiting
- University of California Los Angeles Semel Institute Division of Child & Adolescent Psychiatry, Los Angeles
AWARE: Management of ADHD in Autism Spectrum Disorder
RecruitingPhase 4
- Children's Hospital Los Angeles, Los Angeles
The Myelin Disorders Biorepository Project
RecruitingObservational study
- Children's Hospital of Los Angeles, Los Angeles
About Attention Deficit Hyperactivity Disorder
Does your child have trouble paying attention? This may be a symptom of attention deficit hyperactive disorder (often called ADHD or ADD). Read more.
More about Attention Deficit Hyperactivity Disorder on MedlinePlus
Attention Deficit Hyperactivity Disorder trials in other cities
- Boston, MA10 studies
- Cincinnati, OH8 studies
- Philadelphia, PA6 studies
- Austin, TX6 studies
- Washington, DC5 studies
- Pittsburgh, PA5 studies
- Orlando, FL5 studies
- Las Vegas, NV5 studies
- New York City, NY4 studies
- Memphis, TN4 studies
- Baltimore, MD4 studies
- Durham, NC4 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)73 studies
- Breast Cancer72 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.